Ads
related to: multiple myeloma versus normal spep lab work chart printable- Patient Factors & Impacts
Optimal Management
Review the Critical Factors
- Importance of MRD-
The Importance of Achieving MRD
Negativity for Impacting Outcomes
- Recent Myeloma Research
Explore Recent Findings
in Myeloma Research
- Transform Myeloma
Multiple Myeloma Information
and Resources for HCPs
- Patient Factors & Impacts
Search results
Results from the WOW.Com Content Network
Serum protein electrophoresis (SPEP or SPE) is a laboratory test that examines specific proteins in the blood called globulins. [1] The most common indications for a serum protein electrophoresis test are to diagnose or monitor multiple myeloma , a monoclonal gammopathy of uncertain significance (MGUS), or further investigate a discrepancy ...
Serum protein electrophoresis showing a paraprotein (spike/peak in the gamma zone) in a patient with multiple myeloma.. A myeloma protein is an abnormal antibody (immunoglobulin) or (more often) a fragment thereof, such as an immunoglobulin light chain, that is produced in excess by an abnormal monoclonal proliferation of plasma cells, typically in multiple myeloma or Monoclonal gammopathy of ...
[clarification needed] The normal value of β 2 microglobulin is < 2 mg/L. [11] However, with respect to multiple myeloma, the levels of β 2 microglobulin may also be at the other end of the spectrum. [12] Diagnostic testing for multiple myeloma includes obtaining the β 2 microglobulin level, for this level is an important prognostic indicator.
Monoclonal gammopathy, also known as paraproteinemia, is the presence of excessive amounts of myeloma protein or monoclonal gamma globulin in the blood. It is usually due to an underlying immunoproliferative disorder or hematologic neoplasms, especially multiple myeloma. It is sometimes considered equivalent to plasma cell dyscrasia.
Light chain multiple myeloma is diagnosed in patients who have: a) the criteria for diagnosis of multiple myeloma except having a serum free light chain ratio outside the normal range of 0.26 to 1.65 without evidence of an intact immunoglobulin or free heavy chain; or b) an extreme free light chain ratio, i.e. outside the range of 0.02 to 100 ...
MGUS is a relatively stable condition afflicting 3% of people aged 50 and 5% of people aged 70; it progresses to multiple myeloma at a rate of 0.5–1% cases per year; smoldering multiple myeloma does so at a rate of 10% per year for the first 5 years, but then falls off sharply to 3% per year for the next 5 years and thereafter to 1% per year.
Ads
related to: multiple myeloma versus normal spep lab work chart printable